Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
825.00    0.00 (0.00%)
Bid:
820.00
Ask:
845.00
Spread: 25.00 (3.049%)
Market Cap: £134.64m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Pre-Close Statement

10 Jan 2012 07:01

RNS Number : 2559V
Arbuthnot Banking Group PLC
10 January 2012
 



 

For Immediate Release

 

PRESS RELEASE 10 January 2012

 

 

 

 ARBUTHNOT BANKING GROUP PLC

 

 

PRE-CLOSE STATEMENT

 

 

Overall 2011 has been a successful year for Arbuthnot Banking Group PLC ("ABG" or the "Group"). The economic and business environment remained difficult in 2011 but ABG has taken some major steps, creating significant value for shareholders and positioning the Group to enable it to take advantage of the opportunities that are currently available.

 

The two most important events during the year were the IPO of Secure Trust Bank PLC ("STB") and the sale of Arbuthnot Securities Limited ("ASL").

 

The Group's capital position has been further strengthened by the IPO of STB. Arbuthnot Latham and STB remain highly liquid and both banks are continuing to grow their balance sheet and fee income.

 

The sale of ASL requires regulatory approval before it can be completed and this was not received before the year end. The results will therefore, include approximately £8 million trading losses for the year and £3.5 million of provisions in respect of the costs of an employee share scheme but will exclude the final loss on sale which is expected to be approximately £1 million. ASL's results for the year will be reported as discontinued operations.

 

STB continues to work on significant organic and external business opportunities. However, in respect of the consumer finance joint venture previously mentioned by ABG, despite exhaustive efforts we have been unable to agree a structure which meets the regulatory requirements and falls within our risk appetite; consequently the joint venture will not be proceeding as expected. As a result anticipated income associated with the joint venture has not been received and some extra costs associated with carrying excess deposits have been incurred. 

 

Accordingly, ABG expects profits before tax in 2011 for the continuing operations to be around £5.0 million. In addition ABG expects to record in its profit and loss reserves a gain on the sale of the shares in STB of approximately £16.5 million.

 

STB is also making a pre close statement today which should be read in conjunction with this statement.

 

Enquiries:

 

Arbuthnot Banking Group PLC Tel: 020 7012 2400

Henry Angest, Chairman and Chief Executive

Andrew Salmon, Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

 

Hawkpoint Partners Limited (Nominated Adviser) Tel: 020 7665 4500

Lawrence Guthrie

 

Numis Securities Limited Tel: 020 7260 1000

Christopher Wilkinson

Mark Lander

 

Pelham Bell Pottinger Tel: 020 7861 3232

Ben Woodford

Dan de Belder

 

 

Notes to editors:

Arbuthnot Banking Group consists of three main subsidiaries providing banking services to a wide cross-section of clients.

 

Arbuthnot Latham is the private banking and wealth management arm of the group. It provides banking, financial planning and investment management services to clients.

 

The group also has a full-service, integrated investment bank, Arbuthnot Securities, which offers a full range of institutional stockbroking and corporate advisory services and is focused on UK growth companies.

 

The retail banking arm of the group is Secure Trust Bank. Secure Trust Bank provides a wide scope of services to customers including personal loans, current and savings accounts and financial advice.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDBIGGBGDC
Date   Source Headline
1st Jun 20267:00 amRNSAdmission of Non-Voting Shares to Trading on AIM
20th May 20267:00 amRNSAppointment of New Non-Executive Director
19th May 20263:45 pmRNSResult of AGM
19th May 20262:34 pmRNSAnnual General Meeting 2026 & Trading Update
26th Mar 20263:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSAudited Final Results for the year to 31/12/2025
11th Mar 20262:34 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPre Close Trading Update
23rd Oct 20257:00 amRNSThird Quarter 2025 Trading Update
22nd Jul 20257:00 amRNSUnaudited results for the six months to 30/06/2025
8th Jul 20257:00 amRNSAppointment of independent non-executive director
21st May 20253:40 pmRNSResult of AGM
21st May 20252:19 pmRNS2025 AGM Trading Update
27th Mar 20257:00 amRNSAudited Final Results for the year ended 31/12/24
20th Feb 20257:00 amRNSPre-Close Trading Update
25th Nov 20242:31 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
12th Aug 20248:59 amRNSChange of Registered Office
23rd Jul 20247:00 amRNSUnaudited results for the six months to 30/06/2024
2nd Jul 20249:41 amRNSAppointment of Independent Non-Executive Director
5th Jun 20243:35 pmRNSHolding(s) in Company
4th Jun 202412:02 pmRNSCompletion of Tier 2 Reg. Cap. Facility Renewal
30th May 20247:00 amRNSNotification of Special and Interim Dividends
22nd May 20243:41 pmRNSResult of AGM
22nd May 20247:00 amRNSAnnual General Meeting 2024 Trading Update
22nd Apr 20243:49 pmEQSQ&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends
8th Apr 20243:50 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth
28th Mar 20247:00 amRNSAudited Final Results
21st Feb 20247:00 amRNSPre Close Trading Update
8th Feb 20241:57 pmRNSDirector/PDMR Shareholding
19th Dec 20232:06 pmRNSRenewal of Tier 2 Regulatory Capital Loan facility
5th Dec 202312:47 pmRNSDirector/PDMR Shareholding
13th Nov 20233:40 pmEQSHardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
30th Oct 202310:34 amRNSDirector/PDMR Shareholding
26th Oct 202310:05 amRNSDirector/PDMR Shareholding
24th Oct 20233:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) Trading update: taking ABG to the next level
19th Oct 20237:00 amRNSThird Quarter 2023 Trading Update
22nd Aug 20237:00 amRNSAppointment of New Directors
4th Aug 202311:15 amEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’23: steering through the interest rate wave
18th Jul 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
31st May 202312:37 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
24th May 20233:23 pmRNSAnnual General Meeting Result - 2023
24th May 20237:00 amRNSAnnual General Meeting 2023 Trading Update
5th May 20233:27 pmRNSHolding(s) in Company
5th May 20238:05 amRNSDirector/PDMR Shareholding
4th May 202311:32 amRNSResult of General Meeting and Total Voting Rights
3rd May 20231:45 pmEQSHardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
14th Apr 20235:30 pmRNSPlacing and Subscription raising £12.0 million
6th Apr 202312:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.